Rodger Samuel Agre, MD | |
880 Alder Ave, Incline Village, NV 89451-8215 | |
(775) 832-5555 | |
(775) 832-5559 |
Full Name | Rodger Samuel Agre |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 880 Alder Ave, Incline Village, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740371228 | NPI | - | NPPES |
002013035 | Medicaid | NV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | MD5740 (Nevada) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rodger Samuel Agre, MD 880 Alder Ave, Incline Village, NV 89451-8215 Ph: (775) 832-5555 | Rodger Samuel Agre, MD 880 Alder Ave, Incline Village, NV 89451-8215 Ph: (775) 832-5555 |
News Archive
"The Obama administration is expected to propose in its fiscal 2011 budget Monday new funding to combat preventable and tropical diseases, malnutrition and other conditions afflicting the world's poor, as part of a strategy to broaden its approach to global health," the Wall Street Journal reports.
Findings from three large, randomized Phase III studies demonstrate the superiority of Tasigna (nilotinib) compared to Glivec (imatinib) at achieving deeper molecular responses across various Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) patient populations, including newly diagnosed patients, patients with residual disease who switched to Tasigna after long-term treatment with Glivec, and patients who failed to respond to frontline Glivec (as defined by 2013 European LeukemiaNet [ELN] guidelines).
The Center for Global Health Policy's "Science Speaks" blog on Friday published two posts reporting on ID Week, which concluded in San Diego on Sunday.
Tests that measure the sense of smell may soon become common in neurologists' offices.
› Verified 1 days ago